Active Rheumatoid Arthritis: Clinical Trials

4 trials for Active Rheumatoid Arthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Recruiting 1
Phase 11Completed 1

Follow Active Rheumatoid Arthritis: new trials by email Literature Review of Active Rheumatoid Arthritis trials Research Report on Active Rheumatoid Arthritis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
ELV001 25 mg, ELV001 75 mg, ELV001 125 mg - Active Rheumatoid Arthritis
Phase 2RecruitingElevara Medicines Limited1802026-02-182026-10-23
Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis
SBI-087, Placebo - Active Rheumatoid Arthritis
Phase 2CompletedPfizer2102009-12-012013-12-03
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
ATN-103, Placebo, Methotrexate - Active Rheumatoid Arthritis
Phase 1 / Phase 2CompletedAblynx, a Sanofi company2522009-09-012013-01-30
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
Tranilast, Placebo - Active Rheumatoid Arthritis
Phase 2CompletedNuon Therapeutics, Inc.2502009-03-012011-01-06

Narrower conditions

Arthritis, Rheumatoid (2)

Broader conditions

Arthritis (2)  ·  Autoimmune Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Immune System Diseases (2)  ·  Joint Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Rheumatic Diseases (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Methotrexate (1)  ·  SBI-087 (1)  ·  tranilast (1)

Sponsors

Ablynx, a Sanofi company (1)  ·  Elevara Medicines Limited (1)  ·  Nuon Therapeutics, Inc. (1)  ·  Pfizer (1)

Countries

Serbia (4)  ·  United States (4)  ·  Argentina (2)  ·  Canada (2)  ·  Germany (2)  ·  Hungary (2)  ·  Mexico (2)  ·  South Africa (2)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Czechia (1)  ·  Japan (1)  ·  Poland (1)  ·  Russia (1)

Top investigators

Josefin-Beate Holz, MD (1)  ·  Michael Kitt, MD (1)